Suppr超能文献

[剖宫产术中的缩宫素。有什么新进展?]

[Oxytocin in cesarean-sections. What's new?].

作者信息

Yamaguchi Eduardo Tsuyoshi, Siaulys Mônica Maria, Torres Marcelo Luis Abramides

机构信息

Hospital Universitário da Universidade de São Paulo (HU-USP), São Paulo, SP, Brasil.

Hospital e Maternidade Santa Joana, São Paulo, SP, Brasil.

出版信息

Rev Bras Anestesiol. 2016 Jul-Aug;66(4):402-7. doi: 10.1016/j.bjan.2014.11.005. Epub 2015 Nov 26.

Abstract

Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10 IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency.

摘要

缩宫素是预防和治疗产后子宫收缩乏力的首选子宫收缩剂。然而,对于剖宫产术中使用的最佳剂量和速度尚无共识。使用高剂量推注(例如10国际单位缩宫素)可导致对患者有害的心血管变化,尤其是在低血容量或心脏储备不足的情况下。此外,长时间使用高剂量缩宫素可能导致子宫肌层中缩宫素受体脱敏,从而导致临床无效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验